Don't trade our lives away

Networks striving for equitable access to medicines

Skip to content

Home
About
Books
Documents
Letters to officials
Press
Publications
Take Action
Texts of agreements
Videos

Letters to officials

Letter from IDA Foundation to Karel de Gucht, 27.12.2011

Letter from DNP+ to Delegation of the European Union to India, 10.12.2010

Letter from DNP+ to British High Commissioner, 10.12.2010

Letter from DNP+ to German Ambassador, 10.12.2010

Letter from DNP+ to French Ambassador, 10.12.2010

Letter from MSF to European Trade Commissioner Karel de Gucht, 08.11.2010

Letter from Oxfam India to Indian Prime Minister, 06.10.2010

Letter from NGOs to Indian Prime Minister, 28.09.2010

Letter from European Parliament Working Group on Innovation, Access to Medicines and Poverty-Related Diseases to Trade Commissioner Karel de Gucht, 22.04.2010

Letter from Cancer Patients Aid Association to Mr. Sajjad H. Karim, Member of the European Parliament, 14.10.2008

Share this:

Like this:

Be the first to like this page.

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

Notify me of follow-up comments via email.

Email Subscription

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 95 other followers
Search for:
Link
Take Action
- avaaz.org: Protect our Pharmacy Industry! Sign the petition
- MSF "Hands off" campaign – Sign-on letter
Archives
Recent Posts
Categories

RSS
Tags
ACTA Agreement on Trade-Related Aspects of Intellectual Property Rights Aids Anand Sharma Antiretroviral drug Barack Obama Bayer Brussels Cipla Compulsory license Delhi DNP+ Doha Declaration EU European Commission European Parliament European Union Foreign direct investment FTA Generic drug Hands off HIV/Aids Imatinib India Indian Patent Office Intellectual property Karel de Gucht Malaysia Manmohan Singh Médecins Sans Frontières Natco Novartis Office of the United States Trade Representative Oxfam Patent Pharmaceutical industry Protest Sorafenib Supreme Court of India TPPA Trans-Pacific Strategic Economic Partnership TRIPS U.S. United States World Trade Organization
What is it all about?

For millions of people in the developing world, access to essential medicines is often a question of life and death. Most of them rely on the affordable generic medicines being produced by countries like India. Backed by the big multinational pharma companies, US, European Union and European Free Trade Association are pushing for aggressive trade policies to restrict the supply and production of the generic medicines. The attack is taking various forms but with a single handed objective: Pushing for TRIPS plus provisions through Free Trade Agreements, international treaties, border measures etc. The impact of such actions could be devastating and result in loss of millions of lives in absence of affordable medicines.

"Dont Trade Our Lives Away" blog provides articles, opinions, documents, news reports, pictures, videos providing an insight on latest international developments that can have a direct impact on access to medicines such as on-going bilateral trade negotiations – India-EU FTA, TPPA and also international treaties like Anti-Counterfeiting Trade Agreement.

Don't trade our lives away

Theme: Twenty Ten Blog at WordPress.com.

Follow

Follow “Don't trade our lives away”

Get every new post delivered to your Inbox.

Join 95 other followers

Powered by WordPress.com

Send to Email Address Your Name Your Email Address

Cancel

Post was not sent - check your email addresses!

Email check failed, please try again

Sorry, your blog cannot share posts by email.